Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Robert G, Tieleman"'
Autor:
Michiel Rienstra, Harry J Crijns, Dominik Linz, Robert G Tieleman, Isabelle C van Gelder, Martin EW Hemels, Ulrich Schotten, Bart A Mulder, Yuri Blaauw, Bastiaan Geelhoed, Bao-Oanh Nguyen, Vanessa Weberndorfer, Mirko De Melis, Martijn E Van De Lande, Neda Khalilian Ekrami, Coert OS Scheerder
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Background Sex differences in atrial fibrillation (AF) are observed in terms of comorbidities, symptoms, therapies received, AF progression and cardiovascular complications.Methods We assessed the differences in prevalence and the determinants of AF
Externí odkaz:
https://doaj.org/article/c57df07e8ecc4efe9fe8df051fce5b01
Autor:
Michiel Rienstra, Robert G Tieleman, Isabelle C van Gelder, Bart A Mulder, Yuri Blaauw, Eng S Tan, Federico T Magni, Hessel F Groenveld, Neda Khalilian Ekrami, Vijay Dayalani, Ans CP Wiesfeld
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objectives Pulmonary vein isolation (PVI) is widely accepted as an effective and safe treatment for symptomatic atrial fibrillation (AF). However, data on sex-related differences and associations with clinical outcome and safety of PVI with cryoballo
Externí odkaz:
https://doaj.org/article/9a2d71bec5b0462b8446c07d68321861
Autor:
Federico T. Magni, Bart A. Mulder, Hessel F. Groenveld, Ans C. P. Wiesfeld, Robert G. Tieleman, Moniek G. Cox, Isabelle C. Van Gelder, Tom Smilde, Eng S. Tan, Michiel Rienstra, Yuri Blaauw
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionPulsed field ablation (PFA) was recently introduced for the treatment of symptomatic atrial fibrillation (AF) with the claim of selectively ablating the myocardium while sparing surrounding tissues. We present our initial experience with
Externí odkaz:
https://doaj.org/article/64490f928ef647c88a9867a7f47f96cc
Autor:
Michiel Rienstra, Robert G Tieleman, Isabelle C van Gelder, Bart A Mulder, Yuri Blaauw, Meelad I H Al-Jazairi, Yong E S Tan, Ans C P Wiesfeld, Federico T Magni, Hessel F Groenveld
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Introduction Pulmonary vein isolation (PVI) is an important treatment for atrial fibrillation (AF). However, many patients need more than one procedure to maintain long-term sinus rhythm. Even after two PVIs some may suffer from AF recurrences. We ai
Externí odkaz:
https://doaj.org/article/52943ef3eb924dab9896c00015a5d5db
Autor:
Bao Oanh Nguyen, E.P.J. Petra Wijtvliet, Anne H. Hobbelt, Simone I.M. De Vries, Marcelle D. Smit, Robert G. Tieleman, Dirk Jan Van Veldhuisen, Harry J.G.M. Crijns, Isabelle C. Van Gelder, Michiel Rienstra
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 31, Iss , Pp 100673- (2020)
Background and aim: Physical inactivity is associated with an increased prevalence of atrial fibrillation (AF). We aim to evaluate whether cardiac rehabilitation (CR) motivates patients to become and stay physical active, and whether CR affects sinus
Externí odkaz:
https://doaj.org/article/0a589bd60d244b8fa7d83302c8055f99
Autor:
Marco Alings, Frans H Rutten, Bart van den Bemt, Ewoud J Van Dijk, Suzanne C Cannegieter, Menno V Huisman, Michiel Rienstra, Frederikus A Klok, Geert-Jan Geersing, Marc A Brouwer, Robert G Tieleman, Gordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, Anouk P van Alem, Lucas VA Boersma, Hugo ten Cate, Charles JHJ Kirchhof, Harry JGM Crijns, Arif Elvan, Isabelle C van Gelder, Joris R de Groot, Frank R den Hartog, Jonas SSG de Jong, Sylvie de Jong, Timo Lenderink, Justin G Luermans, Joan G Meeder, Ron Pisters, Peter Polak, Frans Smeets, Giovanni JM Tahapary, Luc Theunissen, Serge A Trines, Pepijn van der Voort, Martin EW Hemels
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Introduction Anticoagulation therapy is pivotal in the management of stroke prevention in atrial fibrillation (AF). Prospective registries, containing longitudinal data are lacking with detailed information on anticoagulant therapy, treatment adheren
Externí odkaz:
https://doaj.org/article/36dfb623da8849bd801197b90789f8e0
Autor:
Marinus van Hulst, Maarten J Postma, Maartje S Jacobs, Bert Loef, Auke C Reidinga, Robert G Tieleman
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
ObjectiveCritically ill patients admitted to the intensive care unit (ICU) often develop atrial fibrillation (AF), with an incidence of around 5%. Stroke prevention in AF is well described in clinical guidelines. The extent to which stroke prevention
Externí odkaz:
https://doaj.org/article/9b5c96bd5faf41a3ad3eb505e99af13f
Autor:
Thomas M. Gorter, Dirk J. van Veldhuisen, Bart A. Mulder, Vicente A. Artola Arita, Vanessa P. M. van Empel, Olivier C. Manintveld, Robert G. Tieleman, Alexander H. Maass, Kevin Vernooy, Isabelle C. van Gelder, Michiel Rienstra
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 11; Pages: 3682
Journal of Clinical Medicine, 12(11):3682. Multidisciplinary Digital Publishing Institute (MDPI)
Journal of Clinical Medicine, 12(11):3682. Multidisciplinary Digital Publishing Institute (MDPI)
Background: Atrial fibrillation (AF) is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and has a negative impact on outcome. Reliable data on prevalence, incidence, and detection of AF from contemporary, pro
Autor:
Vicente Artola Arita, Martijn E Van De Lande, Neda Khalilian Ekrami, Bao-Oanh Nguyen, Joost M Van Melle, Bastiaan Geelhoed, Ruben R De With, Vanessa Weberndörfer, Ömer Erküner, Hans Hillege, Dominik Linz, Hugo Ten Cate, Henri M H Spronk, Tim Koldenhof, Robert G Tieleman, Ulrich Schotten, Harry J G M Crijns, Isabelle C Van Gelder, Michiel Rienstra
Publikováno v:
Europace, 25(4), 1323-1331. Oxford University Press
Arita, V A, Van de Lande, M E, Ekrami, N K, Nguyen, B-O, Van Melle, J M, Geelhoed, B, De With, R R, Weberndorfer, V, Erkuner, O, Hillege, H, Linz, D, Ten Cate, H, Spronk, H M H, Koldenhof, T, Tieleman, R G, Schotten, U, Crijns, H J G M, Van Gelder, I C & Rienstra, M 2023, ' Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation : data from the RACE V study ', Europace, vol. 25, no. 4, pp. 1323–1331 . https://doi.org/10.1093/europace/euac268
Arita, V A, Van de Lande, M E, Ekrami, N K, Nguyen, B-O, Van Melle, J M, Geelhoed, B, De With, R R, Weberndorfer, V, Erkuner, O, Hillege, H, Linz, D, Ten Cate, H, Spronk, H M H, Koldenhof, T, Tieleman, R G, Schotten, U, Crijns, H J G M, Van Gelder, I C & Rienstra, M 2023, ' Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation : data from the RACE V study ', Europace, vol. 25, no. 4, pp. 1323–1331 . https://doi.org/10.1093/europace/euac268
Aims The recent 4S-AF (scheme proposed by the 2020 ESC AF guidelines to address stroke risk, symptom severity, severity of AF burden and substrate of AF to provide a structured phenotyping of AF patients in clinical practice to guide therapy and asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e789f623bce6e1674add2a8167841c5a
https://research.rug.nl/en/publications/dc1bca07-da76-46d9-9744-816b388cec86
https://research.rug.nl/en/publications/dc1bca07-da76-46d9-9744-816b388cec86
Autor:
Lisa A de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G Tieleman, Menno V Huisman, Maarten J Postma, Marinus van Hulst
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222658 (2019)
IntroductionRandomized clinical trials (RCTs) and real-world data (RWD) in patients with atrial fibrillation have shown that-compared to vitamin K antagonists (VKAs)-non-VKA oral anticoagulants (NOACs) are at least as effective in the prevention of i
Externí odkaz:
https://doaj.org/article/fcd6a7083c5348e8adbc791dc683e0ba